Home » Authors » James Etheridge

Articles by James Etheridge

France Biotech Condemns Research Tax 'Scandal'

Dec. 5, 2007

By James Etheridge

Fovea Enters Ophthalmology Collaboration with Genzyme

Nov. 28, 2007

By James Etheridge

Fovea Enters Ophthalmology Collaboration with Genzyme

Nov. 28, 2007

By James Etheridge

Cerep Sells Hesperion To CRO Averion In €25M Deal

Nov. 14, 2007

By James Etheridge

Cerep Sells Hesperion To CRO Averion In €25M Deal

Nov. 14, 2007

By James Etheridge

No Abstract

Diatos Releases Doxorubicin Data, Delves Into Toxicology

Oct. 24, 2007

By James Etheridge

Diatos Releases Doxorubicin Data, Delves Into Toxicology

Oct. 24, 2007

By James Etheridge

Cellectis and Servier Enter Cell Engineering Alliance

Oct. 17, 2007

By James Etheridge

Cellectis and Servier Enter Cell Engineering Alliance

Oct. 17, 2007

By James Etheridge

French Biotech Growing But Still Lagging Behind

Oct. 10, 2007

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...